FCPM III SERVICES B.V.
Follow13F filer, CIK 2013410, NAARDEN, Netherlands
FCPM III SERVICES B.V. reported $1,060,669,027 across 15 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 96.41% of the portfolio.
Accepted , ingested 13F-HR 0001193125-26-462149
- Period
- 2026-09-30
- Reported value
- $1.06B
- Holdings
- 15
- Top 10 weight
- 96.41%
- New
- 4
- Sold out
- 0
Part of the filer group FCPM III SERVICES B.V.
Forbion Growth III Management B.V.Forbion Growth Management B.V.
- Forbion Growth III Management B.V.
- Forbion Growth Management B.V.
- Forbion IV Management B.V.
- Forbion Ventures Fund VII Cooperatief U.A.
- Forbion Ventures VII Management B.V.
- Forbion Growth Opportunities Fund III Cooperatief U.A.
Largest buys vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| BRVEnew | +21,826,024 | $441M |
| KRSAnew | +2,192,155 | $70.1M |
| MPLTadded | +1,201,928 | $12.2M |
| AURAadded | +1,195,066 | $7.51M |
| TARSnew | +64,087 | $5.04M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Largest sells vs the previous quarter
| Security | Shares change | Approx. value |
|---|---|---|
| REPLreduced | -1,087,868 | -$14.4M |
| VORreduced | -712,075 | -$13.6M |
| DYNreduced | -261,460 | -$4.21M |
Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.
Holdings, Q3 2026
Share positions as resolved from 13F-HR 0001193125-26-462149, largest first. % of portfolio is the value over $1,060,669,027, the sum of the share positions whose value is usable for ratios (method).
| Security | History | Shares | Value | % of portfolio | Change | Latest event | Timeline |
|---|---|---|---|---|---|---|---|
| BRVEBRAVEHEART BIO INC | 21,826,024 | $441M | 41.57% | new | Timeline | ||
| NAMSNEWAMSTERDAM PHARMA COMPANY | 8,490,353 | $206M | 19.47% | 0 | Timeline | ||
| KRSAKORSANA BIOSCIENCES INC | 2,192,155 | $70.1M | 6.61% | new | Timeline | ||
| VORVOR BIOPHARMA INC | 3,405,279 | $65M | 6.13% | -712,075 | Timeline | ||
| DYNDYNE THERAPEUTICS INC | 3,586,796 | $57.8M | 5.45% | -261,460 | Timeline | ||
| DMRADAMORA THERAPEUTICS INC | 2,441,000 | $51.9M | 4.9% | 0 | Timeline | ||
| MPLTMAPLIGHT THERAPEUTICS INC | 4,428,328 | $45.1M | 4.25% | +1,201,928 | Timeline | ||
| AURAAURA BIOSCIENCES INC | 5,248,841 | $33M | 3.11% | +1,195,066 | Timeline | ||
| CBIOCRESCENT BIOPHARMA INC. | 2,022,679 | $29.5M | 2.78% | +344,827 | Timeline | ||
| REPLREPLIMUNE GROUP INC | 1,720,500 | $22.8M | 2.15% | -1,087,868 | Timeline | ||
| ENGNENGENE HOLDINGS INC | 9,632,561 | $19.3M | 1.82% | 0 | Timeline | ||
| BCYCBICYCLE THERAPEUTICS PLC | 3,468,430 | $12.8M | 1.2% | 0 | Timeline | ||
| TARSTARSUS PHARMACEUTICALS INC | 64,087 | $5.04M | 0.47% | new | Timeline | ||
| ENGNWENGENE HOLDINGS INC | 2,878,148 | $576K | 0.05% | 0 | Timeline | ||
| LSTALISATA THERAPEUTICS INC | 297,478 | $428K | 0.04% | new | Timeline |
How Q3 2026 was built
Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).
| Filing | Role | Amendment | Filed | Accepted | Ingested |
|---|---|---|---|---|---|
| 13F-HR 0001193125-26-462149 | base | 2026-11-16 |
Filings
Every filing of this filer: 13F reports and notices, the 13D and 13G it filed or is a reporting person of, and Forms 3, 4 and 5 it reported as an owner.
| Filing | Subject | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001193125-26-462149 | Quarter ended 2026-09-30 | 2026-11-16 | ||
| 13F-HR 0001193125-26-350207 | Quarter ended 2026-06-30 | 2026-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-225423 | Quarter ended 2026-03-31 | 2026-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-26-053151 | Quarter ended 2025-12-31 | 2026-02-17 | acceptance time not in the bulk data set | |
| 13F-HR 0001193125-25-281853 | Quarter ended 2025-09-30 | 2025-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-008060 | Quarter ended 2025-06-30 | 2025-08-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-005517 | Quarter ended 2025-03-31 | 2025-05-15 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-25-002356 | Quarter ended 2024-12-31 | 2025-02-14 | acceptance time not in the bulk data set | |
| 13F-HR 0000950123-24-011523 | Quarter ended 2024-09-30 | 2024-11-14 | acceptance time not in the bulk data set | |
| 13F-HR 0001802806-24-000036 | Quarter ended 2024-06-30 | 2024-08-08 | acceptance time not in the bulk data set | |
| 13F-HR 0001802806-24-000028 | Quarter ended 2024-03-31 | 2024-05-03 | acceptance time not in the bulk data set | |
| 13F-HR 0001802806-24-000019 | Quarter ended 2023-12-31 | 2024-03-07 | acceptance time not in the bulk data set |